The Cost Conundrum: Pharmacists at the Crossroads of Evidence and Affordability

Read full text
Authors: Dejan Landup, Emily Hanners Dunn, Elizabeth Van Dril, Robert J. DiDomenico
Cited by: 0
References: 9

Abstract

Dr. Dejan Landup received speaker honoraria from Pharmacy Times, Pharmacy Times Continuing Education, and American College of Clinical Pharmacy (ACCP). Dr. Emily Hanners Dunn received speaker honoraria from the Illinois Council for Health System Pharmacists and ACCP. Dr. Elizabeth Van Dril has received research support from the Bayer Corporation, Women in Nephrology, and the National Kidney Foundation; served as a member of a Data Safety Monitoring Board (DSMB) for a study funded by the National Heart, Lung, and Blood Institute; and serves as an editorial board member for Diabetes, Obesity, and Cardiometabolic Care. Dr. Robert J. DiDomenico received research support from CSL Behring, Institute for Clinical and Economic Review, Cook County Department of Public Health, and the Otho S.A. Sprague Institute; is a member of a DSMB for a study funded by the Agency for Healthcare Research and Quality; is a member of the ACCP Board of Regents; and serves on the editorial boards of the Journal of the American College of Clinical Pharmacy (Associate Editor), Circulation: Heart Failure, and DiPiro's Pharmacotherapy: A Pathophysiologic Approach (Assistant Editor).

Fields of Study & Subjects

Pharmaceutical Economics and Policy Pharmacy and Medical Practices Health Systems Economic Evaluations Quality of Life

Publication details

Journal / source
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Volume
9
Issue
2
Pages
e70181–e70181
Publication date
1 February 2026
Language
EN